1. Adams R & Murray F. 1978. Improving Your Health with Vitamin C. Larchmont.
2. Afroz M. 1975. Vitamins C and B. Journal of the American Medical Association 232:3, 246.
3. Altschule MD. 1976. Is It True What They Say about Cholesterol? Executive Health 12:no.11.
4. Amato G. 1937. Azione dell'acido ascorbico sul virus fisso della rabbia e sulla tossina tetanica. Giornale di Batteriologia Virologia et Immunologia (Torino), vol.19:pp.843-849.
5. Anderson JT, Keys A. 1957. Safflower Oil, Hydrogenated Safflower Oil and Ascorbic Acid Effects on Serum Cholesterol in Man. Federation Proceedings (Bethesda), vol.16:p.380.
6. Anderson R. 1982. Effects of Ascorbate on Normal and Abnormal Leukocyte Functions, in Vitamin C: New Clinical Applications in Immunology. Liped Metabolism and Cancer, ed. A. Hanck. Hans Huber, Bern, PP.23-34.
7. Anderson R, Lukey PT. 1987. A Biological Role for Ascorbate in the Selective Neutralization of Extracellular Phagocyte-derived Oxidants. In: Third Conference on Vitamin C. 1987. Annals of the New York Academy of Sciences. Vol.498.
8. Baetgen D. Results of the Treatment of Epidemic Hepatitis in Children with High Doses of Ascorbic Acid in the Years 1957-1958. Medizinische Monatschrift, vol.15:pp.30-36. 1961.
9.Bailer JC III EM. 1986. Progress Against Cancer. New England J. Medicine 314, 1226-32.
10. Baker III EM. 1971. Ascorbic Sulfate: A Urinary Metabolite of Ascorbic Acid in Man. Science, vol.173:pp.826-827.
11.Banerjee S. 1944. Part IV. Effect of Vitamin C on the Insulin Content of the Pancreas of Guinea Pigs. Annals of bio-chemistry and Experimental Medicine, vol.4:pp.33-36.
12. Banerjee S, Baudyopadhyay A. 1963. Plasma Lipids in Scurvy: Effect of Ascorbic Acid Supplement and Insulin Treatment. Proceedings Society Experimental Biology and Medicine, vol.112:pp.372-374.
13. Bartelheimer H. 1939. Vitamin C in the Treatment of Diabetes. Die Medizinische Welt, vol.13:117-120.
14. Bartlett MK, Jones CM, Ryan AE. 1942. Vitamin C and Wound Healing. II. Ascorbic Acid Content and Tensile Strength of Healing Wounds in Human Beings. New England Journal of Medicine 226:474-481.
15. Bates CJ, Mandal AR, Cole TJ. 1977. HDL-Cholesterol and Vitamin C Status. The Lancet 3:611.
16.Baur H. 1952. Poliomyelitis Therapy with Ascorbic Acid. Helvetia Medica Acta, Vol. 19:pp.470-474.
17.Baur H, Staub H. 1954. Therapy of Hepatitis with Ascorbic Acid Infusions. Schweizerische Medizinische Wochenschrift, vol.84:pp.595-597.
18.Becker et al RR. 1953. Ascorbic Acid Deficiency and Cholesterol Synthesis. Journal American Chemical Society, vol.75:p.2020.
19.Behrens WA, Madere R. A Procedure for the Determination of Ascorbic and Dehydroascorbic Acid in Biological Fluids, Tissues, and Foods. In: Third Conference on Vitamin C. 1987. Annals of the New York Academy of Sciences. Vol.498.
20. Berge GE. 1989. Esterified Polyascorbate: An Alternative for Ailments in Support and Movement Structure in Dogs.
21. Bingham R. 1984. Fight Back Against Arthritis. Desert Arthritis Medical Clinic.
22. Biser S. 1989. The Great Vitamin C Myth Exploded. Health Discoveries Newsletter.
23.Bjelke E. 1974. Epidermological Studies of Cancer of the Stomach, Colon and Rectum with Special Emphasis on the Role of Diet. Scan J. Gastro. 9(31) 1-235.
24.Blanchard J, Achari R, Harrison GG and Conrad KA. 1984. The Influence of Vitamin C on Antipyrine Pharmacokinetics in Elderly Men. Biopharm. & Drug disp. 5: 43-54.
25.Blanchard J, Hochman D. 1984. Effects of Vitamin C on Caffeine Pharmacokinetics in Young and Aged Guinea Pigs. Drug-Nutr. Inter. 2: 243-55.
26.Blanchard J, Conrad KA 1988. Comparison of Plasma, Mononuclear and Polymorphonuclear Leucocyte Vitamin C Levels in Young and Elderly Women During Depletion and Supplementation. European J. Clin. Nutrition. 43: 97-106.
27.Blanchard J, Conrad KA, Mead KA, Gary PJ. 1989. Vitamin C Disposition in Young and Elderly Men. Manuscript.
28.Bland J. 1987. The Latest Developments in the Therapy and Biochemistry of Vitamin C. Seminar Transcript.
29.Bland J. 1989. Reducing the Risk to Coronary Heart Disease: Appraisal of Progress. In: Nutrition, Health and Peace. Pauling Symposia. Vol I. Linus Pauling Institute. Jariwalla RJ, Schwoebel SL (eds).
30.Bland J. 1989. The Key to the Power of Vitamin C and its Metabolites. Keats Publishing.
31.Booker WM et al. 1957. Cholesterol - Ascorbic Acid Relationship. American J. Phys. 189:335-7.
32.Bordia A. 1980. The Effect of Vitamin C on Blood Lipids, Fibrinolytic Activity, and Platelet Adhesiveness in Patients with Coronary Artery Disease. Atherosclerosis 35:2, 181-187.
33.Bradford, Allen & Culbert. 1985. Oxidology. Bradford Foundation.
34. Brandt R, Guyer KE, Banks WL. Jr. 1974. A Simple Method to Prevent Vitamin C Interference with Urinary Glucose Determinations. Clinica Chimica Acta 51:103-104.
35. Brighthope I. 1988. The AIDS Fighters. Keats Publishing.
36.Burns, Rivers & Machlin (eds.). 1987. Third Conference on Vitamin C. Annals of the New York Academy of Sciences. 498.
37.Bush MJ & Verlangieri AJ. 1987. An Acute Study on the Relative Gastro-Intestinal Absorption of a Novel Form of Calcium Ascorbate. Res. Comm. Chem Path. Pharm. 57 (1): 137-40.
38.Calabrese EJ, Stoddard A, Leonard DA, Dinardi SR. 1987. The Effects of Vitamin C Supplementation on Blood and Hair Levels of Cadmium, Lead and Mercury. In: Third Conference on Vitamin C. Annals of the New York Academy of Sciences. Vol.498.
39.Calleja HB, Brooks RH. 1960. Acute Hepatitis Treated with High Doses of Vitamin C. Ohio State Medical Journal, vol.56:pp.821-823.
40.Cameron E, Campbell A. 1974. The Orthomolecular Treatment of Cancer. II. Clinical Trial of High-Dose Ascorbic Acid Supplements in Advanced Human Cancer. Chemical-Biological Interactions 9:4, 285-315.
41.Cameron E. 1976. Supplemental Ascorbate in the Supportive Treatment of Cancer: Prolongation of Survival Times in Terminal Human Cancer. Proceedings of the National Academy of Sciences 73:10, 3685-3689.
42.Cameron E & Pauling L. 1978. Supplemental Ascorbate in the Supportive Treatment of Cancer.
43.Cameron E & Pauling L. 1979. Cancer and Vitamin C. Linus Pauling Institute. Revolution of Prolongation of Survival Times in Terminal Haaaa Cancer. PNAS 75: 4538-42.
44.Cameron E. 1987. The Vitamin C and Cancer Story: A Personal Perspective. In: Nutrition, Health and Peace. Pauling Symposia. Vol I. Linus Pauling Institute. Jariwalla RJ, Schwoebel SL (eds).
45.Castelli WP. 1986. Incidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels. The Framingham Study. JAMA 256: 2835-38. -1,0
46. Cathcart RF. 1981. Vitamin C Titrating to Bowel Tolerance, Anascorbemia, and Actue Induced Scurvy. Medical Hypotheses 7: 1359-76.
47. Cathcart RF. 1984. Vitamin C in the Treatment of Acquired Immune Deficiency Syndrome (AIDS). Medical Hypotheses. 14:423-33.
48. Cathcart RF. 1988. AIDS Treatment Using Ascorbic Acid. Townsend Letter for Doctors.
49. Cathcart RF. 1989. Letter. Personal Communication.
50. Challem JJ. 1983. Vitamin D Updated. Keats Publishing.
51. Charleston SS & Clegg KM. 1972. Ascorbic Acid and the Common Cold. The Lancet 1: 140.
52. Cheraskin E, Ringsdorf WM, Jr. 1964. Vitamin C State in a Dental School Patient Population. Journal of the Southern California State Dental Association. 32:10, 375-378.
53. Cheraskin E et al. 1968. Effect of Diet Upon Radiation Response in Cervical Carcinoma & Uterus: A Preliminary Report. Cyptologica 12: 433-438.
54. Cheraskin E, Ringsdorf WM & Sisley E. 1983. The Vitamin C Connection. Getting well and stayin well with Vitamin C. Harper & Row.
55. Chope HD & Breslow L. 1955. Nutritional Status of the Aging American. J Public Health 46: 61-7.
56. Choroka PB. 1988. Cancer 1988. Is a Healing Peace in the Government's War on Cancer Finally at Hand?
57. Cohen AM, Bavly S, Poznanski R. 1961. Change of Diet of Yemenite Jews in Relation to Diabetes and Ishaemic Heart-Disease. The Lancet 2:1399-1401.
58. Cortinovis et al A. 1960. Ascorbic Acid and Atherosclerosis Giornale di Gerontologia (Firenze), vol.8:pp.28-31.
59. Cousins N. 1983. The Healing Heart. Norton.
60. Cox MA. 1981. Oxycal vs Arthritis. Ralph Tanner Associates.
61. Creagan et al. 1979. Failure of High-Dose Vitamin C (Ascorbic Acid) Therapy to Benefit Patients with Advanced Cancer: A Controlled Trial. New England Journal of Medicine 301:13, 687-690.
62. Dahl H, Degre M. 1976. The Effect of Ascorbic Acid on Production of Human Interferon and the Antiviral Activity In Vitro. Acta Pathologica et Microbiologica Scandinavica. 84:5, 280-284.
63. Dainow I. 1943. Treatment of Herpes Zoster with Vitamin C. Dermatologia, vol.68:pp.197-201.
64. Dalton WL. 1962. Massive Doses of Vitamin C in the Treatment of Viral Diseases. Journal Indiana State Medical Association, vol.55:pp.1151-1154.
65. Davies S & Stewart A. 1987. Nutritional Medicine. Pan Books.
66. Dawson EB, Harris WA, Rankin WE, Charpentier LA, McGanity WJ. 1987. Effects of Ascorbic Acid on Male Fertility. In: Third Conference on Vitamin C. Annals of the New York Academy of Sciences. Vl.498.
67. Deeniham MJ. 1989. Acute Oral Toxicity. Toxicology Laboratory Services, Northview Pacific Laboratories Inc.
68. Degkwitz E. 1987. Some Effects of Vitamin C May Be Indirect, Since It Affects the Blood Levels of Cortisol and Thyroid Hormones. In: Third Conference on Vitamin C. Annals of the New York Academy of Sciences. Vol.498.
69. Dent et al FM American Journal of Physiology, vol.163:p.700.1950.
70. Di Fabio A. 1982. Rheumatoid Diseases Cured at Last. Rheumatoid Disease Foundation.
71. Di Fabio A. 1988. The Art of Getting Well. Rheumatoid Disease Foundation.
72. Diliberto EJ Jr, Menniti FS, Knoth J, Daniels AJ, Kizer JS, Viveros OH. Adrenomedullary Chromaffin Cells as a Model to Study the Neurobiology of Ascorbic Acid: From Monooxygenation to Neuromodulation. In: Third Conference on Vitamin C. 1987. Annals of the New York Academy of Sciences. Vol.498.
73. Dokter CE. 1983. Clinical Evaluation.
74. Erasmus U. 1986. Fats and Oils, the Complete Guide to Fats and Oils in Health and Nutrition. 1986 Alive Books Publishing.
75. Erasmus U. 1988. Fats that Heal Fats that Kill. Lecture. Cancer Control Society Convention.
76. Evans W. 1938. Vitamin C in Heart Failure. Lancet, vol.1:pp.308-309.
77. Federova EP. 1960. Long Term Ascorbic Acid Therapy for Patients with Coronary Atherosclerosis. Sovetskaia Meditsiana (Moskva), vol.25:pp.56-60.
78. Fidanza A, Audisio M, Mastroiacovo P. 1982. Vitamin C and Cholesterol, in Vitamin C: New Clinical Applications in Immunology, Lipid Metabolism, and Cancer, ed. A. Hanck. Hans Huber, Bern,pp.153-171.
79. Free V, Sanders P. 1978. The Use of Ascorbic Acid and Mineral Supplements in the Detoxification of Narcotic Addicts. Journal of Orthomolecular Psychiatry 7:4, 264-270.
80. Furth A & Harding J. 1989. Why Sugar is Bad for You. New Scientist. 23 Sept., 44-7.
81. Gale ET, Thewlis MW. 1953. Vitamin C and P in Cardiovascular and Cerebrovascular Disease. Geriatrics, vol.8:pp.80-87.
82. Gey KF, Stahelin HB, Evans A. Relationship of Plasma Level of Vitamin C to Mortality from Ischmic Heart Disease. In: Third Conference on Vitamin C. 1987. Annals of the New York Academy of Sciences. Vol.498.
83. Ginter et al E. 1969. The Effect of Chronic Hypovitaminosis C on the Metabolism of Cholesterol and Atherogenesis in Guinea Pigs. Journal of Atherosclerosis Research, vol. 10; pp.341-352.
84. Ginter E. 1973. Cholesterol: Vitamin C Controls Its Transformation to Bile Acids. Science 179:74, 702-704.
85. Ginter E et al. 1977. `Effects of Ascorbic Acid on Plasma Cholesterol in Humans in a Long-Term Experiment.' International Journal of Vitamin Nutrition Research 47(2):123-134.
86. Ginter E. 1980. The Role of Vitamin C in Lipid Metabolism. Presented at a symposium entitled `Vitamin C-Its Pharmacologic Activity and Nutritional Aspects,' Mexico City, Mexico, National Commission of Fruiticulture.
87. Ginter E. 1982. Vitamin C in the Control of Hypercholesteremia in Man, in Vitamin C: New Clinical Applications in Immunolgy, Lipid Metabolism, and Cancer, ed. A. Hanck. Hans Huber, Bern, pp.137-152.
88. Ginter E, Jurcovincova M. Chronic Vitamin C Deficiency Lowers Fractional Catabolic Rate of Low-Density Lipoproteins in Guinea Pigs. In: Third Conference on Vitamin C. 1987. Annals of the New York Academy of Sciences. Vol.498.
89. Gkembotski CC. The Role of Ascorbic Acid in the Biosynthesis of the Neuroendocrine Peptides a-MSHd TRH. In: Third Conference on Vitamin C. 1987. Annals of the New york Academy of Sciences. Vol. 498.
90. Goertz E. 1986. Clinical Data on Ester-C. Report on 20 Cases.
91. Graham J & Odent M. 1986. The Z. Factor. How Zinc is Vital to Your Health. Thorsons.
92. Greer E. 1955. Vitamin C in Acute Poliomyelitis. Medical Times (Manhasset), vol.83:pp.1160-1161.
93. Griffith HW. 1988. Complete Guide to Vitamins Minerals & Supplements. Fisher.
94. Gsell O, Kalt F. 1954. Treatment of Epidemic Poliomyelitis with High Doses of Ascorbic Acid. Schweizerische Medizinische Wochenschrift, vol.84:pp.661-666.
95. Haid H. 1941. Vitamin C in Blood in Insulin Shock. Zeitschrift fur Klinische Medizin, vol.139:p.485.
96. Hallberg L, Brune M, Rossander-Hulthen L. Is There a Physiological Role of Vitamin C in Iron Absorption. In: Third Conference on Vitamin C. 1987. Annals of the New York Academy of Sciences. Vol.498.
97. Harakeh S & Jariwalla RJ. 1989. Suppression of HIV Replication and Virus Infectivity In Vitro By Ascorbate. Manuscript. Submitted.
98.Harris A, Robinson AB, Pauling L. 1973. Blood Plasma L-Ascorbic Acid Concentration for Oral L-Ascorbic Acid Dosage up to 12 Grams per Day. International Research Communications System, page 19, December.
99. Hausman P. 1987. The Right Dose. How to Take Vitamins & Minerals Safely. Rodale Press.
100. Hay LL. 1984. You Can Heal Your Life. Eden Grove.
101. Heikkila RE, Manzino L. Ascorbic Acid, Redox Cycling, Lipid Peroxidation and the Binding of Dopamine Receptor Antagonists. In: Third Conference on Vitamin C. 1987. Annals of the New York Academy of Sciences. Vol.498.
102. Herbert V, Jacob E. 1974. Destruction of Vitamin B by Ascorbic Acid. Journal of the American Medical Association 230:241-242.
103. Hogenkamp HPC. 1980. The Interaction Between Vitamin B and Vitamin C. The American Journal of Clinical Nutrition 33:1, 1-3.
104. Holden M, Resnick RJ. 1936. In Vitro Action of Synthetic Crystalline Vitamin C (Ascorbic Acid) on Herpes Virus. Journel of Immunology, vol.31:pp.455-462.
105. Holden M, Molloy E. 1937. Further Experiments on Inactivation of Herpes by Vitamin C (1-ascorbic acid). Ibid., vol.33:pp.251-257.
106. Hornig G, Weiser H, Weber F & Wiss (O). 1973. Effect of massive Doses of Ascorbic Acid on its Catabolism & Guinea Pigs. Inter. J. Vit. & Nutrition Res 43(1) 28-33.
107. Hornig D. Recent advances in Vitamin C Metabolism. 1974. In: Second Conferemce on Vitamin C. Annals of the New York Academy of Science, 91-103.
108. Horrobin DF, Manku MS, Oka M, Morgan RO, Cunnane SC, Ally AI, Ghayur T, Schweitzer M, Karmaki RA. 1979. The Nutritional Regulation of T Lymphocyte Function. Medical Hypotheses 5:969-985.
109. Horrobin DF, Oka M, Manku MS. 1979. The Regulation of Prostaglandin E1 Formation: A Candidate for One of the Fundamental Mechanisms Involved in the Actions of Vitamin C. Medical Hypotheses 5:849-858.
110. Houston RG. 1987. Repression and Reform in the Evaluation of Alternative Cancer Therapies. 1987.
111. Hume & Weyers E. 1973. Changes in Leucocyte Ascorbic Acid during the Common Cold. Scottish Medical J. 18, 3-7.
112. Ibric LLV, Sevanian A. Effects of Ascorbic and Dehydroascorbic Acids on lipid Composition of C H/1OT Cells. In: Third Conference on Vitamin C. 1987. Annals of the New York Academy of Sciences. Vol.498.
113. Jacob RA, Omaye ST, Skala JH, Leggott PJ, Rothman DL, Murray PA. Experimental Vitamin C Depletion and Supplementation in Young Men: In: Third Conference on Vitamin C. 1987. Annals of the New York Academy of Sciences. Vol.498.
114. Jaffe RM, Kasten B, Young DS, MacLowry JD. 1975. False-Negative Stool Occult Blood Tests Caused by Ingestion of Ascorbic Acid (Vitamin C). Annals of Intenal Medicine 83:6, 824-826.
115. Jaffe RM, Lawrence L, Schmid A, MacLowry JD 1979. Inhibition by Ascorbic Acid (Vitamin C) of Chemical Detection of Blood in Urine. American Journal of Clinical Pathology 72:3, 468-470.
116. Jaffe RM, Zierdt W. 1979. A New Occult Blood Test Not Subject to False-Negative Results from Reducing Substances. Journal of Laboratory and Clinical Medicine 93:5, 879-886.
117. Jariwalla RJ, Schwoebel SL (eds). 1987. Nutrition, Health and Peace. Pauling Symposia. Vol I. Linus Pauling Institute.
118. Johnson GE, Obenshain SS. 1981. Nonresponsiveness of Serum High-Density Lipoprotein-Cholesterol to High Dose Ascorbic Acid Administration in Normal Men. American Journal of Clinical Nutrition 34:2088-2091.
119. Jungeblut CW. 1935. Inactivation of Poliomyelitis Virus by Crystalline Vitamin C (Ascorbic Acid). Journal of Experimental Medicine, vol.62:pp. 517-521.
120. Jungeblut CW. 1939. Further Observations on Vitamin C Therapy in Experimental Poliomyelitis. Journal of Experimental Medicine, vol.65: pp.127-146. 1937. Ibid., vol.66:pp.459-477, 1937. Ibid., vol.70:pp.315-332.
121. Jungeblut, CW. A Further Contribution to the Vitamin C Therapy in Experimental Poliomyelitis. Journal of Experimental Medicine, vol 70: p.327. 1939.
12. Kallner A. Requirement for Vitamin C Based on Metabolic Studies. In: Third Conference on Vitamin C. 1987. Annals of the New York Academy of Sciences. Vol.498.
123. Kapeghian JC & Verlangieri AJ. 1984. The Effects of Glucose on Ascorbic Acid Uptake in Heart Endothelial Cells: Possible Pathogenesis of Diabetic Angiopathies. Life Sciences, 34: 577-84.
124. Katz SM, DiSilvio TV. 1973. Ascorbic Acid Effects on Serum Glucose Values. Journal of the American Medical Association 224:5, 628.
125. Kirchmair H. 1957. Treatment of Epidemic Hepatitis in Children with High Doses of Ascorbic Acid. Medizinische Monatschrift, vol. 11:pp. 353-357. 1957. Epidemic Hepatitis in Children. Deutsche Gesundheitwesen, vol.12:pp.773-774. 1957. Epidemic Hepatitis in Children and Its Treatment with High Doses of Ascorbic Acid. Ibid., vol. 12: pp. 1525-1536. 1957.
126. Klenner FR. 1948. Virus Pneumonia and Its Treatment with Vitamin C. Southern Medicine and Surgery, vol.110: pp.34-46.
127. Klenner FR. The Treatment of Poliomyelitis and Other Virus Diseases with Vitamin C. Southern Medicine and Surgery, vol. 111: pp. 209-214. 1949. Massive Doses of Vitamin C and the Virus Diseases. Ibid., vol. 113: pp. 101-107. 1951. The Vitamin and Massage Treatment for Acute Poliomyelitis. Ibid., vol. 114: pp. 194-197. 1952. The Use of Vitamin C as an Antibiotic. Journal of Applied Nutrition, vol 6: pp. 274-278. 1953. The Folly in the Continued Use of a Killed Polio Virus Vaccine. Tri-State Medical Journal, pp. 1-8. Feb. 1959.
128. Klenner FR. 1951. Massive Doses of Vitamin C and the Viral Diseases. Southern Medicine and Surgery 113:101-107.
129. Klenner FR. 1971. Observations on the Dose and Administration of Ascorbic Acid When Employed Beyond the Range of a Vitamin in Human Pathology. Journal of Applied Nutrition 23:3-4, 61-88.
130. Kligler IJ, Bernkopf H. 1937. Inactivation of Vaccinia Virus by Ascorbic Acid and Glutathione. Nature, vol. 139:pp.965-966.
131. Kolmakov VN 1957. Effect of Vitamin C on Hypercholesterolmia in Fasting Rabbits. Voprosy Meditsinskoi Khimii (Moskva), vol.3:pp.414-419.
132. Lamden MP, Chrystowski GA. 1954. Urinary Oxalate Excretion by Man Following Ascorbic Acid Ingestion. Proceedings of the Society for Experimental Biology and Medicine 85:190-192.
133. Langenbusch W, Enderling A. 1937. Einfluss der Vitamine auf das Virus der Maul-und Klavenseuch. Zentralblatt fur Bakteriologie, vol.140:pp.112-115.
134. Lee W, Davis KA, Rettmer LR, Labbe RF. 1988. Ascorbic Acid Status: Biochemical and Clinical Considerations. Am J. Clin. Nutr. 48: 286-90.
135. Leibovitz B. 1984. Carnitine: The Vitamin B Phenomenon. Dell, New York.
136. Levine M & Morita K. 1985. Ascorbic Acid in Endocrine systems. In: Vitamins and Hormones. Vol 42. Academic Press.
137. Levine M, Morita K, Heldman & Pollard HB. 1985. Ascorbic Acid Regulation of Norephinephrine Biosynthesis in Isolated Chromaffin Granules from Bovine Adrenal Medulla. J. Biol. Chem.. 260 (29): 15598-15603.
138. Levine M. 1986. New Concepts in the Biology and Biochemistry of Ascorbic Acid. The New England Journal of Medicine Vol. 314 No. 14: 892-902.
139. Levine M. 1986. Ascorbic Acid Specifically Enhances Dopamine Monooxygenase Activity in Resting and Stimulated Chromaffin Cells. J. Biol. Chem. 261(16): 7347-56.
140. Levine M, Hartzell W. 1987. Ascorbic Acid: The Concept of Optimum Requirements. In: Third Conference on Vitamin C. 1987. Annals of the New York Academy of Sciences. Vol.498.
141. Lohmann W. Ascorbic Acid and Cancer. In: Third Conference on Vitamin C. 1987. Annals of the New York Academy of Sciences. Vol.498.
142. Lojkin M. 1936. Contributions of the Boyce Thompson Institute, vol.8, No.4. LF Martin. Proceedings Third International Congress of Microbiology, New York, 1940, p.281.
143. Lominski I. 1936. Inactivation du bacteriophage par l'acide ascorbique. Comptes Rendus des Seances de la Societe de Biologie et de Ses Filliales (Paris),vol.122:pp.766-768.
144. Marcus M, Prabhudesai M, Wassef S. 1980. Stability of Vitamin B in the Presence of Ascorbic Acid in Food and Serum: Restoration by Cyanide of Apparent Loss. American Journal of Clinical Nutrition 33:137-143.
145. Marcus, M. 1981. `Vitamin B12: Response to Dr. Herbert.' The American Journal of Clinical Nutrition 34:1622-1624.
146. Markham RG. 1989. Compositions and Methods for Administering Vitamin C. United States Patent No. 4,822,816.
147. Martin S & Chaitow L. 1988. A World Without Aids. Thorsons.
148. Mayson JS, Schumaker O, Nakamura RM. 1972. False-Negative Tests for Urinary Glucose in the Presence of Ascorbic Acid. American Journal of Clinical Pathology 58:3, 297-299.
149. McCormick WJ. 1957. Coronary Thrombosis. A New Concept of Mechanism and Etiology. Clinical Medicine, pp.839-845.
150. Melethil S, Subrahmanyam MB, Chang CJ, Mason WD. Megadoses of Vitamin C: A Pharmacokinetic Evaluation. In: Third Conference on Vitamin C. 1987. Annals of the New York Academy of Sciences. Vol.498.
151. Menten ML, King CG. 1935. The Influence of Vitamin C Level upon Resistance to Diptheria Toxin. Journal of Nutrition. vol.10:pp.141-153.
152. Milner JE. 1980. Ascorbic Acid in the Prevention of Chromium Dermatitis. Journal of Occupational Medicine 22:1, 51-52.
153. Moertel CG, Fleming TR, Creagan ET, Rubin J, O'Connell MJ, Ames MM. 1985. High-Dose Vitamin C versus Placebo in the Treatment of Patients with Advanced Cancer Who Had No Prior Chemotherapy. New England Journal of Medicine 312:137-141.
154. Morishige F, Murata A. Prolongation of Survival Times in Terminal Human Cancer by Administration of Supplemental Ascorbate. Journal of the International Academy of Preventive Medicine 5:1, 47-52, 1978.
155. Morishige F, Murata A. 1978. Vitamin C for Prophylaxis of Viral Hepatitis B in Transfused Patients. Journal of the International Academy of Preventive Medicine 5:54-58.
156. Mueller L. 1989. Dysplasia's End. Outdoor Life. April.
157. Mumma RO. 1968. Ascorbic Acid as a Sulfating Agent. Biochimica et Biophysica Acta, vol.165:pp.571-573. Mumma RO, Verlangieri AJ. 1971. In Vivo Sulfation of Cholesterol by Ascorbic Acid 3-Sulfate as a Possible Explanation for the Hypocholestemic Effects of Ascorbic Acid. Federation Proceedings, vol.30, No.2.
158. Murata A. 1975. Virucidal Activity of Vitamin C: Vitamin C for Prevention and Treatment of Viral Diseases. Proceedings of the First Intersectional Congress of Microbiological Societies, Science Council of Japan 3:432-442.
159. Nahata MC, McLeod. 1978. Noneffect of Oral Ascorbic Acid on Urinary Copper Reduction Glucose Test. Diabetes Care 1:1, 34-35.
160. Newmark HL, 1976. Stability of Vitamin B in the Presence of Ascorbic Acid. American Journal of Clinical Nutrition 29:6, 645-649.
161. Niki E. Interaction of Ascorbate and a-Tocopherol. In: Third Conference on Vitamin C. 1987. Annals of the New York Academy of Sciences. Vol.498.
162. Omaye ST, Schaus EE, Kutnink MA, Hawkes WC. Measurement of Vitamin C in Blood Components by High-Performance Liquid Chromatography: Implication in Assessing Vitamin C Status. In: Third Conference on Vitamin C. 1987. Annals of the New York Academy of Sciences. Vol.498.
163. Paez de la Torre JM. 1945. Ascorbic Acid in Measles. Archives Argentinos do Pediatria, vol.24:pp.225-227. Paterson JC. 1941. Some Factors in the Causation of Intimal Hemorrhages and in the Precipitation of Coronary Thrombi. Canadian Medical Association Journal, vol. 44: pp.114-120.
164. Pauling L. 1970. Vitamin C the Common Cold & the Flu. Berkley.
165. Pauling L. et al. 1985. Effect of Ascorbic Acid on the Incidence of Spontaneous Mammary Tumors in RIII PNAS 82:5185-89
166. Pauling L. 1986. How to Live Longer and Feel Better. Avon Books.
167. Pecoraro RE, Chen MS. Ascorbic Acid Metabolism in Diabetes Mellitus. In: Third Conference on Vitamin C. 1987. Annals of the New York Acadamy of Sciences. Vol.498.
168. Pfeiffer CC. 1987. Mental illness and Schizophrenia. The Nutrition Connection. Thorsons.
169. Pfleger R, Scholl F. 1937. Diabetes and Vitamin C. Wiener Archiv fur Innere Medizin, vol.31:PP.219-229.
170. Prauer, HW 1971. Vitamin C and Tests for Diabetes. New England Journal of Medicine 284:23, 1328.
171. Prinz Wetal. 1977. The Effect of Ascorbic Acid Supplementation on Some Parameters of Human Immunological Defence System. Int. J. Vit. & Nut. Research 47, 248-56.
172. Project, Cure Center for Alternative Cancer Research. 2020 K Street NW Suite 350, Washington DC 20069. (202) 293-3479.
173. Richards RK, Kueter D, Klatt TJ. 1941. Effect of Vitamin C deficiency on different types of barbiturates. Proc. Soc. Exp. Biol. Med. 48: 403-9.
174. Rineheart JF, Mettier SR. 1934. The Heart Valves and Muscle in Experimental Scurvy with Superimposed Infection. American Journal of Pathology. vol.10: pp.61-79.
175. Ringsdorf WM, JR, Cheraskin E. 1978. Lingual Ascorbic Acid Test. Quintessence International 12:1707, 81-85.
176. Ringsdorf WM, Jr, Cheraskin E. 1979. Vitamin C and the Metabolism of Analgesic, Antipyretic, and Anti-Inflammatory Drugs: A Review. Alabama Journal of Medical Sciences. 16:3, 217-220.
177. Ringsdorf WM Jr, Cheraskin E. 1982. Vitamin C and Human Wound Healing. Oral Surgery 53:231-236.
178. Rivers JM. Safety of High-level Vitamin C Ingestion. In: Third Conference on Vitamin C.1987. Annals of the New York Academy of Sciences. Vol.498.
179. Recommended Dietary Allowances. National Academy of Sciences. Washington. Nat. Acad. Press 19?? p7-75.
180. Rogoff et al JM. 1944. Vitamin C and Insulin Action. Pennsylvania Medical Journal, vol.47:pp.579-582.
181. Romney SL, Basu J, Vermund S, Palen PR, Duttagupta C. Plasma Reduced and Total Ascorbic Acid in Human Uterine Cervix Dysplasiaas and Cancer. In: Third Conference on Vitamin C. 1987. Annals of the New York Academy of Sciences. Vol.498.
182. Rose RC. Ascorbic Acid Protection against Free Radicals. In: Third Conference on Vitamin C. 1987. Annals of the New York Academy of Sciences. Vol.498.
183. Rossander L, Hallberg L, Bjorn-Rasmussen E. 1979. Absorption of Iron from Breakfast Meals. American Journal of Clinical Nutrition 32:12, 2484-2489.
184. Ruskin SL. 1952. Crystalline Calcium Ascorbate and Methods of Preparing Same. United States Patent Office No. 2,596,103.
185. Sabin AB. Vitamin C in Relation to Experimental Poliomyelitis, Journal of Experimental Medicine, vol. 69: pp.507-515. 1939.
186. Samitz MH. 1970. Ascorbic Acid in the Prevention and Treatment of Toxic Effects of Chromates. Acta Dermatovenereologica 50:1, 59-64.
187. Scher J. Vitamin C as an Adjunct in Methadone Maintenance and Detoxification of Narcotic Addicts. Journal of Orthomolecular Psychiatry 5:3, 191-198.
188. Schmidt, Karl-Heinz et al. 1981. `Urinary Oxalate Excretion After Large Intakes of Ascorbic Acid in Man.' The American Journal of Clinical Nutrition 34:305-311.
189. Sebrov KR. 1956. Prophylaxis and Treatment of Arteriosclerosis with Ascorbic Acid. Terapevticheskii Arkhiv (Moskva), vol.28:pp.55-65
190. Shaffer CF. 1970. Ascorbic Acid and Atherosclerosis. American Journal of Clinical Nutrition, vol.23:pp.27-30.
191. Sigal A, King CG. 1936. The Relationship of Vitamin C to Glucose Tolerance in the Guinea Pig. Journal of Biological Chemistry, vol.116:pp.489-492.
192. Smith JL, Hodges RE. Serum Levels of Vitamin C in Relation to Dietry and Supplemental Intake of Vitamin C in Smokers and Nonsmokers. In: Third Conference on Vitamin C. 1987. Annals of the New York Academy of Sciences. Vol.498.
193. Sokoloff et al B. 1967. Effect of Ascorbic Acid on Certain Blood Fat Metabolism Factors in Animals and Man. Journal of Nutrition, vol.91:pp.107-118.
194. Spiegel HE & Pinili E. 1974. Effect of Vitamin C on SGOT, SGPT, LDH & Bilirubin. Med. J. of Aus 2(7) 265-6.
195. Spittle CR. 1971. Atherosclerosis and Vitamin C. The Lancet 2:1280-1281.
196. Spittle CR. 1974. The Action of Vitamin C on Blood Vessels. American Heart Journal 88:3, 387-388.
197. Stahelin HB, Gey KF, Brubacher G. Plasma Vitamin C and Cancer Death: The Prospective Basel Study. In: Third Conference on Vitamin C. 1987. Annals of the New York Academy of Sciences. Vol.498.
198. Stewart et al CT. 1952. Factors Determining Effect of Insulin on Metabolism of Glucose in Ascorbic Acid Deficiency and Scurvy in the Monkey. American Journal of Diseases of Children, vol.84:pp.677-690.
199. Stone I. 1965. Studies of a Mammalian Enzyme System for Producing Evolutionary Evidence. Mon. Amer. J. Physical Arthrop. 23: 83-86.
200. Stone I. 1972. The Healing Factor: Vitamin C against Disease. Grosset & Dunlap.
201. Stone N, Meister A. 1962. Function of Ascorbic Acid in the Conversion of the Proline to Collagen Hydroxyproline. Nature, vol.194:p.555.
202. Szent-Gyorgyi A. 1937. Studies on Biological Oxidation and Some of Its Catalysts. Szeged, Hungary.
203. Tajima S, Pinnell SR. 1982. Regulations of Collagen Synthesis by Ascorbic Acid: Asorbic Acid Increases Type I Procollagen mRNA. Biochemical and Biophysical Research Communications 106:632-637.
204. Tannenbaum ST, Wishnok JS. Inhibition of Nitrosamine Formation by Ascorbic Acid. In: Third Conference on Vitamin C. 1987. Annals of the New York Academy of Sciences. Vol.498.
205. Taylor S. 1937. Scurvy and Carditis. Lancet, vol. 1: pp.973-979.
206. Thomas CB, Holljes HWD, Eisenberg FF. 1961. Observations on Seasonal Variations in Total Serum Cholesterol Level Among Healthy Young Prisoners. Annals of Internal Medicine 54:3, 413-430.
207. Thomas M, Hughes RE. 1985. `Evaluation of Threonic Acid Toxicity in Small Animals,' Food Chemistry 17:79-83.
208. Thomas WR, Holt RG. 1978. `Vitamin C and Immunity: An Assessment of the Evidence.' Clinical Experimental Immunology 32:370-379.
209. Tiapina LA. 1961. The Effect of Ascorbic Acid on Blood Lipids in Essential Hypertension and Atherosclerosis. Cor et Vasa (Praha), vol.3:pp.98-106.
210. Trang JM, Blanchard J, 1982. The Effect of Vitamin C on the Pharmacokinetics of caffeine in Elderly Men. Amer. J. Clin. Nutri. 35: 487-94.
211. Trimmer RW, Lundy CJ. 1948. A Nutrition Survey in Heart Desease. American Practitioner, vol.2: pp.448-450.
212. TSAO, CS. SALIMI, SL. PAULING, L 1982. Lack of Effect of Ascorbic Acid on Calcium Excretion. IRCS Medical Science 10:738.
213. TSAO, C. SALIMI, S. L. (1984) Effects of Large Intake of Ascorbic Acid on Urinary and Plasma Oxalic Acid Levels. International Journal of Nutrition and Vitamin Research 54:245-249.
214. TSAO, CS. SALIMI, SL. 1984. Evidence of Rebound Effect with Ascorbic Acid. Medical Hypotheses 13:303-310.
215. Turley SD, West CE, Horton BJ. 1976. The Role of Ascorbic Acid in the Regulation of Cholesterol Metabolism and in the pathogenesis of Atherosclerosis. Atherosclerosis 24:1-18.
216. Uverskaia VT. 1958. Influence of Ascorbic Acid on Cholesterolemia and Acid-Base Balance in Patients with Hypertensive Disease and Atherosclerosis. Trudy Leningradskogo Sanitarnogigienicheskogo Meditsinskego Instituta, vol.40:pp.150-158.
217. Vallance S. (1977). Relationships between Ascorbic Acid and Serum Proteins of the Immune System. British Medical Journal 2, 437-438.
218. Vargus Magne R. 1963. Vitamin C in Treatment of Influenza. El Dia Medico, vol.35:pp.1714-1715.
219. Verlangieri AJ. 1973. Possible Biological & Pharmacological Significance of L-Ascorbic Acid & L-Ascorbic Acid z-Sulphate on Chol???? Metabolism, Metabolic Sulfation and Atherogeneses. 1973. Ph. D. Thesis. Penn. State Univ.
220. Verlangieri AJ & Stevens JW. 1979. L-Ascorbic Acid: Efects on Aortic Glycosaminoglycan S Incorporated in Rabbit Induced Atherogenesis Blood Vessels. 16(4): 177-85.
221. Verlangieri AJ & Sestito J. 1981. Effect of Insulin on Ascorbic Acid Uptake by Heart Endothelial Cells: Possible Relationship to Retinal Atherogeneses. Life Sciences 29, 5-9.
222. Verlangieri AJ. Bush MJ & Kapeghian. 1984. Duplex Ultrasound Analysis of the Carotid Arteries in Macaca Fascicularis. J. Card. Ultrason. Vol. 2 (4): 293-302.
223. Verlangieri AJ. 1985. The Role of Vitamin C in Diabetic and Nondiabetic Atherosclerosis. Bulletin, Bureay of Pharm. Services. Univ. Miss. Vol 21.
224. Verlangieri AJ. Cardin BA & Bush M. 1985. The Interaction of Aortic Glycosaminoglycans and -Inulin Endothelial Permeability in Cholesterol Induced Rabbit Atherogenesis.
225. Verlangieri AJ. 1987. Acute Study to Determine the Relative Gastro-Intestinal Absorption of Ester C as Compared to L-Ascorbic Acid.
226. Verlangieri AJ. 1988. Acute study to Determine the Relative Rate of Absorption and Excretion of Ester-C Calcium Ascorbate, USP Calcium Ascorbate with an added Metabolite and `Another Commercial Ascorbate'.
227. Verlangieri AJ. Acute Study to determine the Relative Rate of Absorption and Excretion of Ester C, Calcium Ascorbate, Calcium Ascorbate and Calcium Threorate and Relative Vitamin C.
228. Verlangieri AJ. 1988. Acute Study to Determine the Relative Rate of Absorption and Excretion of USP Calcium Ascorbate and Ester-C Calcium Ascorbate.
229. Verlangieri AJ. 1989. The Effect of Calcium-L-Threonate on the Uptake of C-L-Ascorbic Acid into 3T3 Mouse Fibroblasts.
230. Verlangieri AJ. 1989. Effects of Vitamin C and Vitamin E on Induced Primate Atherosclerosis. Manuscripted submitted.
231. Wapnick AA. 1969. The Effect of Ascorbic Acid Deficiency on Desferrioxamine-Induced Urinary Iron Excretion. British Journal of Haematology 17:6, 563-568.
232. Wassertheil-Smoller S. 1981. Dietary Vitamin C and Uterine Cervical Dysplasia. American Journal of Epidemiology 114:5, 714-724.
233. Waugh WA, King CG. 1932. Isolation and Identification of Vitamin C. Journal of Biological Chemistry 97:325-331.
234. Werbach MR. 1987. Nutritional Influences on Illoscases. Thorsons.
235. Willis GC. 1953. An Experimental Study of the Intimal Hemorrhages and in the Precipitation of Coronary Thrombi. Canadian Medical Association Journal, vol.69:pp.17-22.
236. Willis et al GC. 1954. Serial Arteriography in Atherosclerosis. Canadian Medical Association Journal, vol. 71: pp.562-568.
237. Willis GC, Fishman S. 1955. Ascorbic Acid Content of Human Arterial Tissue. Canadian Medical Association Journal, vol.72:pp.500-503.
238. Willis GC. 1957. The Influence of Ascorbic Acid upon the Liver. Canadian Medical Association Journal, vol.76:pp.1044-1048.
239. Willis GC. 1957. The Reversibility of Atherosclerosis. Canadian Medical Association Journal of Nutrition, vol.77:pp.106-109.
240. Wilson, PW, Garrison RJ, 1980. Prevalence of Coronary Heart Disease in the Framingham Offspring Study: Role of Lipoprotein Cholesterol. Am. J. Cardio. 46: 649-54.
241. Wright JV & Suen RM. 1987. A Clinical Study of Ester-C vs L-Ascorbic Acid. Meridian Valley Clinical Laboratory.
242. Yonemoto RH, Chretien PB, Fehniger TF. 1976. Enhanced Lymphocyte Blastogenesis by Oral Ascorbic Acid. Proceedings of the American Association for Cancer Research 17:288.
243. Yudkin J, Edelman I, Hough L, (EDS.) 1971. Sugar: Chemical, Biological, and Nutritional Aspects of Sucrose. Daniel Davey, Hartford, Conn.
244. Yudkin J. 1972. Sweet and Dangerous. Peter H. Wyden, New York.
245. Zannoni VG, Brodfuehrer JI, Smart RC, Susick Jr RL. Ascorbic Acid, Alcohol, and Environmental Chemicals. In: Third Conference on Vitamin C. 1987. Annals of the New York Academy of Sciences. Vol.498.
246. Zureick M. 1950. Treatment of Shingles and Herpes with Vitamin C Intravenously. Journal des Praticiens, vol.64: p.586.
